Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT06163781

Appropriate Use of Blood Cultures in the Emergency Department Through Machine Learning

Led by Amsterdam UMC, location VUmc · Updated on 2024-05-07

7584

Participants Needed

1

Research Sites

175 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to study whether the use of our blood culture prediction tool is non-inferior to current practice and if it can improve certain outcomes in all adult patients presenting to the emergency department with a clinical indication for a blood culture analysis (according to the treating physician). The primary endpoint is 30-day mortality. Key secondary outcomes are: * hospital admission rates * in-hospital mortality * hospital length-of-stay. In the intervention group, the physician will follow the advice of our blood culture prediction tool. In the comparison group all patients will undergo a blood culture analysis.

CONDITIONS

Official Title

Appropriate Use of Blood Cultures in the Emergency Department Through Machine Learning

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age �30; 18 years
  • Have a clinical indication for a blood culture analysis (according to the treating physician)
  • Have sufficient data recorded (laboratory results and vital sign measurements) for a prediction to be made (at least 20% of the needed parameters)
Not Eligible

You will not qualify if you...

  • Central Venous Line (CVL) or Peripherally Inserted Central Catheter (PICC) in situ
  • Neutrophil count < 0.5 * 10^9/L
  • Candidemia or S. aureus bacteraemia in the past 3 months
  • Most likely diagnosis of endocarditis/spondylodiscitis/infected prosthetic material
  • Pregnant or breastfeeding patients
  • Not capable of giving informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Amsterdam UMC - location AMC

Amsterdam, Netherlands

Actively Recruiting

Loading map...

Research Team

P

Prabath WB Nanayakkara, MD, PhD

CONTACT

S

Sheena C Bhagirath, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here